Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/splisense-announces-fda-clearance-of-investigational-new-drug-application-for-phase-2-initiation-of-spl84-for-the-treatment-of-cystic-fibrosis-302107114.html
https://www.prnewswire.com/news-releases/splisense-successfully-completed-phase-1-study-of-spl84-rna-based-therapy-for-the-treatment-of-cystic-fibrosis-301918897.html
https://www.clinicaltrialsarena.com/news/splisense-trial-spl84-cystic-fibrosis/
https://www.prnewswire.com/news-releases/splisense-initiates-phase-12-study-of-spl84-rna-based-therapy-for-the-treatment-of-cystic-fibrosis-301702837.html
https://www.prnewswire.com/news-releases/splisense-announces-fda-and-ema-grant-orphan-drug-designation-to-spl84-23-1-for-the-treatment-of-cystic-fibrosis-301453367.html